Targeting reciprocal feedback inhibition in the clinic: ARN509 and PI3K pathway inhibition in patients with metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract


Authors: Rathkopf, D. E.; Carver, B. S.; Chen, Y.; Morris, M. J.; Danila, D. C.; Slovin, S. F.; Autio, K. A.; DeNunzio, M.; Sawyers, C. L.; Scher, H. I.
Abstract Title: Targeting reciprocal feedback inhibition in the clinic: ARN509 and PI3K pathway inhibition in patients with metastatic castration-resistant prostate cancer (mCRPC)
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613202143
PROVIDER: wos
DOI: 10.1200/jco.2014.32.15_suppl.TPS5106
Notes: Meeting Abstract: TPS5106 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Charles L Sawyers
    225 Sawyers
  2. Susan Slovin
    254 Slovin
  3. Michael Morris
    577 Morris
  4. Yu Chen
    133 Chen
  5. Karen Anne Autio
    119 Autio
  6. Dana Elizabeth Rathkopf
    272 Rathkopf
  7. Brett Stewart Carver
    143 Carver
  8. Howard Scher
    1130 Scher
  9. Daniel C Danila
    154 Danila